Copy
Connect with us on LinkedIn and visit us at clinicalresearchcurrents.com
May 24, 2019
Good morning! Here is your weekly roundup of the latest news and trends in clinical research. -- Teresa

North America leads the clinical trials market

The global clinical trials market size is expected to reach USD 6.89 billion by 2026, and one of the key drivers is the globalization of clinical trials. North America leads the market in terms of revenue share; Phase III trials are expected to dominate the market; and the oncology segment will grow the fastest. (Yahoo Finance)

Verily aims to speed up clinical trials

Verily, the life sciences company owned by Google parent Alphabet, has partnered with Novartis, Sanofi, Otsuka, and Pfizer on a project that aims to speed up clinical trials. The pharma companies will use Verily’s clinical research tools- known as Project Baseline – to try to improve the recruitment of patients into clinical trials and make studies faster and more efficient. (pharmaforum)

Will the smaller clinical trial sites survive?

Increasing competition for a shallow, specialized patient pool is putting pressure on small standalone sites- which may be terminal. One solution may be the formation of site networks. hyperCORE International, a “super network” of clinical research site organizations, has just formed the second largest site network in the world, with more than 80 sites across five countries on two continents. (ACRP Net)

FDA wants to reduce disparities in clinical trials

The U.S. FDA is implementing policies to eliminate health disparities in clinical trials, research, and treatments of chronic, debilitating diseases.  The agency published guidance on the collection of race and ethnicity data in clinical trials, and recently created a Minorities in Clinical Trials Initiative to increase patients’ understanding of the benefits of clinical research. (Health IT Analytics)

Mayo Clinic develops tool to measure the complexity of clinical trials

Mayo Clinic Florida has developed a tool to assess the complexity of a clinical trial that can be applied consistently and comprehensively to studies of all diseases across all types of clinical trials. The complexity assessment can in turn be utilized to determine the trial capacity of a study coordinator. (ACRP Net)

Animal studies should use more diverse and not identical mice

Current research protocols require lab mice to be near-identical, but new research suggests that might not be a good idea. A lot of experimental mice go over what has been called a “clinical trial cliff”: a drug works in mice but fails when tested in people, or has toxic side effects. (COSMOS)

Patient engagement web platform from Icon bolsters clinical connectivity

Icon launches web-based patient engagement platform to provide patients with study-specific information and connectivity. (outsourcing-pharma.com)

Morning walk on California beach

Photo:  T. Gallagher

Some free webinars (go to our website for more webinars and conferences)

Would you like to contribute a blog to Currents?
Submit your article or interview
MISS AN ISSUE? CHECK OUT OUR NEWSLETTER ARCHIVES
Sign up for our list!
Forward this email to a friend

The newsletter is always evolving- tell us what you think! Please send feedback to teresa@clinicalresearchcurrents.com.

Copyright © 2019 San Diego Clinical Research Network, All rights reserved.